On May 17, 2010
Biotechs Avoiding the IPO Pool This Year — Except for Profitable Ikaria
As the market started to recover last fall, it seemed biotechs just couldn’t get lined up to go public fast enough. But subsequent IPO pricings doused that excitement, until Ikaria entered the game.
No tags for this post.
0 Comments